MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 108 filers reported holding MAXCYTE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $777,718 | -30.0% | 250,000 | 0.0% | 0.19% | -15.0% |
| Q2 2023 | $1,111,775 | -7.6% | 250,000 | 0.0% | 0.23% | -12.1% |
| Q1 2023 | $1,202,663 | -9.1% | 250,000 | 0.0% | 0.26% | -10.8% |
| Q4 2022 | $1,323,328 | -18.2% | 250,000 | 0.0% | 0.29% | -14.8% |
| Q3 2022 | $1,618,000 | +39.8% | 250,000 | 0.0% | 0.34% | +41.4% |
| Q2 2022 | $1,157,000 | -34.4% | 250,000 | 0.0% | 0.24% | -23.6% |
| Q1 2022 | $1,764,000 | -30.5% | 250,000 | 0.0% | 0.31% | -21.0% |
| Q4 2021 | $2,538,000 | -16.2% | 250,000 | 0.0% | 0.40% | -19.5% |
| Q3 2021 | $3,027,000 | – | 250,000 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,885,000 | $5,881,200 | 5.55% |
| Vitruvian Partners LLP | 5,043,356 | $15,735,271 | 4.46% |
| Stonepine Capital Management, LLC | 3,761,640 | $11,736,317 | 3.90% |
| Mudita Advisors LLP | 1,390,858 | $4,339,477 | 3.17% |
| RIVER GLOBAL INVESTORS LLP | 1,473,254 | $4,588,359 | 1.07% |
| Casdin Capital, LLC | 1,890,000 | $5,896,800 | 0.65% |
| Portolan Capital Management | 2,143,666 | $6,688,238 | 0.62% |
| Grandeur Peak Global Advisors, LLC | 1,434,819 | $4,476,635 | 0.34% |
| First Light Asset Management, LLC | 1,073,110 | $3,348,103 | 0.32% |
| Granahan Investment Management | 1,975,847 | $6,164,643 | 0.22% |